drugset
drugset / Trial / NCT00653315

Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions

NCT00653315 ↗

Phase 1 Completed 28 enrolled Par Pharmaceutical, Inc. AAI Clinic · collab
RandomizedCrossoverOpen-label

Summary

To compare the relative bioavailability of Kali and Ortho-McNeil's

Timeline

Start
2002-05
Primary completion
2002-08
Completion
2002-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 325 mg —
Subject Tramadol Other / unclassified 37.5 mg —

Indications

No indication recorded.